Using estimated yearly progression rates to compare radiographic data across recent randomised controlled trials in rheumatoid arthritis.
作者信息
Strand V, Landéwé R, van der Heijde D
机构信息
Stanford University, Division of Immunology, Palo Alto, CA, USA.
出版信息
Ann Rheum Dis. 2002 Nov;61 Suppl 2(Suppl 2):ii64-6. doi: 10.1136/ard.61.suppl_2.ii64.
Abstract
摘要
相似文献
1
Using estimated yearly progression rates to compare radiographic data across recent randomised controlled trials in rheumatoid arthritis.
Ann Rheum Dis. 2002 Nov;61 Suppl 2(Suppl 2):ii64-6. doi: 10.1136/ard.61.suppl_2.ii64.
2
Radiographic data from recent randomized controlled trials in rheumatoid arthritis: what have we learned?
Arthritis Rheum. 2003 Jan;48(1):21-34. doi: 10.1002/art.10683.
3
Radiographic progression in rheumatoid arthritis: results of 3 comparative trials.
J Rheumatol. 1995 Sep;22(9):1797-9.
4
Interpreting radiographic data in rheumatoid arthritis.
Ann Rheum Dis. 2003 Jul;62(7):597-604. doi: 10.1136/ard.62.7.597.
5
[Inhibition of radiographic progression in rheumatoid arthritis by anti-rheumatic drugs (DMARDs)].
Clin Calcium. 2007 Apr;17(4):546-52.
6
How to interpret radiological progression in randomized clinical trials?
Rheumatology (Oxford). 2003 Jan;42(1):2-5. doi: 10.1093/rheumatology/keg062.
7
Should radiographic progression still be used as outcome in RA?
Clin Immunol. 2018 Jan;186:79-81. doi: 10.1016/j.clim.2017.07.022. Epub 2017 Jul 22.
8
Is radiographic progression a realistic outcome measure in clinical trials with early inflammatory arthritis?
Clin Exp Rheumatol. 2003 Sep-Oct;21(5 Suppl 31):S37-41.
9
Similar effects of disease-modifying antirheumatic drugs, glucocorticoids, and biologic agents on radiographic progression in rheumatoid arthritis: meta-analysis of 70 randomized placebo-controlled or drug-controlled studies, including 112 comparisons.
Arthritis Rheum. 2010 Oct;62(10):2852-63. doi: 10.1002/art.27592.
10
Paucity of radiographic progression in rheumatoid arthritis treated with methotrexate as the first disease modifying antirheumatic drug.
J Rheumatol. 1999 Oct;26(10):2280-1.
引用本文的文献
1
Biological function integrated prediction of severe radiographic progression in rheumatoid arthritis: a nested case control study.
Arthritis Res Ther. 2017 Oct 25;19(1):244. doi: 10.1186/s13075-017-1414-x.
2
PTGER4 gene variant rs76523431 is a candidate risk factor for radiological joint damage in rheumatoid arthritis patients: a genetic study of six cohorts.
Arthritis Res Ther. 2015 Nov 5;17:306. doi: 10.1186/s13075-015-0830-z.
3
A genetic variant in osteoprotegerin is associated with progression of joint destruction in rheumatoid arthritis.
Arthritis Res Ther. 2014 May 7;16(3):R108. doi: 10.1186/ar4558.
4
Identification of a genetic variant for joint damage progression in autoantibody-positive rheumatoid arthritis.
Ann Rheum Dis. 2014 Nov;73(11):2038-46. doi: 10.1136/annrheumdis-2013-204050. Epub 2013 Aug 16.
5
Clinical, radiographic and functional effectiveness of tocilizumab for rheumatoid arthritis patients--REACTION 52-week study.
Rheumatology (Oxford). 2011 Oct;50(10):1908-15. doi: 10.1093/rheumatology/ker221. Epub 2011 Jul 13.
6
Anakinra for rheumatoid arthritis.
Cochrane Database Syst Rev. 2009 Jan 21(1):CD005121. doi: 10.1002/14651858.CD005121.pub3.
7
Abatacept inhibits progression of structural damage in rheumatoid arthritis: results from the long-term extension of the AIM trial.
Ann Rheum Dis. 2008 Aug;67(8):1084-9. doi: 10.1136/ard.2007.085084. Epub 2007 Dec 17.
8
Remission, a therapeutic goal in inflammatory arthropathies? Clinical data from adalimumab studies.
Drugs. 2006;66(14):1783-95. doi: 10.2165/00003495-200666140-00001.
9
Radiography as primary outcome in rheumatoid arthritis: acceptable sample sizes for trials with 3 months' follow up.
Ann Rheum Dis. 2004 Nov;63(11):1413-8. doi: 10.1136/ard.2003.014043. Epub 2004 Mar 22.
本文引用的文献
1
Etanercept versus methotrexate in patients with early rheumatoid arthritis: two-year radiographic and clinical outcomes.
Arthritis Rheum. 2002 Jun;46(6):1443-50. doi: 10.1002/art.10308.
2
Demonstration of response in rheumatoid arthritis patients who are nonresponders according to the American College of Rheumatology 20% criteria: the paradox of beneficial treatment effects in nonresponders in the ATTRACT trial. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy.
Arthritis Rheum. 2001 Nov;44(11):2703-4. doi: 10.1002/1529-0131(200111)44:11<2703::aid-art451>3.0.co;2-e.
3
Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate. Utilization of Leflunomide in the Treatment of Rheumatoid Arthritis Trial Investigator Group.
Arthritis Rheum. 2001 Sep;44(9):1984-92. doi: 10.1002/1529-0131(200109)44:9<1984::AID-ART346>3.0.CO;2-B.
4
Treatment of active rheumatoid arthritis with leflunomide: two year follow up of a double blind, placebo controlled trial versus sulfasalazine.
Ann Rheum Dis. 2001 Oct;60(10):913-23. doi: 10.1136/ard.60.10.913.
5
Recent rheumatoid arthritis clinical trials using radiographic endpoints--updated research agenda.
J Rheumatol. 2001 Apr;28(4):887-9.
6
Radiography of rheumatoid arthritis in the time of increasing drug effectiveness.
Curr Rheumatol Rep. 2001 Feb;3(1):46-52. doi: 10.1007/s11926-001-0050-1.
7
Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group.
N Engl J Med. 2000 Nov 30;343(22):1594-602. doi: 10.1056/NEJM200011303432202.
8
A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis.
N Engl J Med. 2000 Nov 30;343(22):1586-93. doi: 10.1056/NEJM200011303432201.
9
A comparison of the efficacy and safety of leflunomide and methotrexate for the treatment of rheumatoid arthritis.
Rheumatology (Oxford). 2000 Jun;39(6):655-65. doi: 10.1093/rheumatology/39.6.655.
10
A multicenter, double-blind, dose-ranging, randomized, placebo-controlled study of recombinant human interleukin-1 receptor antagonist in patients with rheumatoid arthritis: radiologic progression and correlation of Genant and Larsen scores.
Arthritis Rheum. 2000 May;43(5):1001-9. doi: 10.1002/1529-0131(200005)43:5<1001::AID-ANR7>3.0.CO;2-P.
Zotero 插件